Synergistic anti-glioma activity of temozolomide and simvastatin through inhibition of the EGFR/AKT/mTOR signaling pathway. // European Journal of Pharmacology. – URL: https://www.sciencedirect.com/science/article/pii/S0014299926009945?dgcid=rss_sd_all
Synergistic anti-glioma activity of temozolomide and simvastatin through inhibition of the EGFR/AKT/mTOR signaling pathway. European Journal of Pharmacology. https://www.sciencedirect.com/science/article/pii/S0014299926009945?dgcid=rss_sd_all
“Synergistic anti-glioma activity of temozolomide and simvastatin through inhibition of the EGFR/AKT/mTOR signaling pathway.” European Journal of Pharmacology.
@article{article138,
title = {Synergistic anti-glioma activity of temozolomide and simvastatin through inhibition of the EGFR/AKT/mTOR signaling pathway},
journal = {European Journal of Pharmacology},
url = {https://www.sciencedirect.com/science/article/pii/S0014299926009945?dgcid=rss_sd_all}
}